HLA genotyping in the international Type 1 Diabetes Genetics Consortium
about
HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families.Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).Summarizing historical information on controls in clinical trialsCan non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms.16(th) IHIW: immunogenomic data-management methods. report from the immunogenomic data analysis working group (IDAWG).High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array™ System for simplified amplicon library preparation.Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years.The HLA-B 3906 allele imparts a high risk of diabetes only on specific HLA-DR/DQ haplotypes.Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.Race-specific type 1 diabetes risk of HLA-DR7 haplotypes.Congruence as a measurement of extended haplotype structure across the genome.Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodiesPrognostic Classification Factors Associated With Development of Multiple Autoantibodies, Dysglycemia, and Type 1 Diabetes-A Recursive Partitioning Analysis.ATPase4A Autoreactivity and Its Association With Autoimmune Phenotypes in the Type 1 Diabetes Genetics Consortium StudyChanges in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.Concordance of next generation sequence-based and sequence specific oligonucleotide probe-based HLA-DRB1 genotyping.The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes.Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complexUse of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populations.Recursive organizer (ROR): an analytic framework for sequence-based association analysis.HLA class I and II alleles are associated with microvascular complications of type 1 diabetes.Receiver operating characteristic analysis of HLA, CTLA4, and insulin genotypes for type 1 diabetes.HLA class II genotyping of African American type 1 diabetic patients reveals associations unique to African haplotypes.Multiple HLA epitopes contribute to type 1 diabetes susceptibilityEffects of the genome on immune regulation in type 1 diabetes.Paradigm shift or shifting paradigm for type 1 diabetes
P2860
Q28397387-F5BBB388-B03E-410E-83BE-F6456D5903C3Q28749882-A53B2A35-D2F2-4CD3-BC1A-A0DF3165502CQ29397593-478CCF54-2848-4102-BCF3-FD08F0FC904DQ30252380-D52BB3B2-7521-4E08-AD76-E32BD520E1B6Q30412750-C467C770-B166-4811-A94B-3AF1124C6AB7Q30583849-0EB3B4CB-F756-447E-A9B9-A93DDE7176D3Q34582241-4C91C423-D630-482C-8797-BB64F7964E9CQ34615329-AEE9BDD8-0BFA-4C71-8EB9-52F6E2091833Q35031671-058EAD66-6DBB-4ACD-95F6-AB7452C7699FQ35064081-266803B4-5AB7-47D6-9486-A17231E7E129Q35344520-9D257F12-A13C-4803-9670-8ADDC264D3CBQ35847732-6E1783DD-9EF9-4AC7-9EAB-9AEA5A242615Q35976503-D927362D-59D1-48EE-B3A6-A7B9A4C4A7D2Q36025138-44761DB9-66B5-482C-9E7C-075E1FE7DD12Q36092700-3E9E8648-A8C4-43A3-8C22-F47EE5F4BB4AQ36092708-59F2797A-4076-45BF-9B80-326EAF8C59F3Q36359462-1C421FB5-26D2-407A-882D-721F59AD1FC6Q36547636-84FD2C54-CC08-4327-BB7C-15BB2F9FCB12Q36722514-93C30A42-8659-4001-93E1-4CB1AB2B8CB7Q36803762-F3F437B7-F1C6-49FC-99D6-40B09C9E2C90Q36931170-7F3AD0A1-F460-464D-86A0-4DE11A145282Q36940316-7A2155DE-20ED-462D-8AD1-2864927212FDQ37106451-985698F7-EBA4-49F6-BE5A-AB459622EAE9Q37110535-6D3DC5DE-0222-42A0-9B8F-730F3B54A22BQ37403330-B0D9C3DA-8BAE-4B17-8417-A43906937A08Q39605597-6F89F49B-D84B-4B83-9100-53FE926F1519Q42536328-303DEB35-B8DA-4221-BD4B-20F3A22BE920
P2860
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
@ast
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
@en
type
label
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
@ast
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
@en
prefLabel
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
@ast
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
@en
P2093
P2860
P356
P1433
P1476
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
@en
P2093
Anna Lisa Fear
Anthony Louey
Brian D Tait
David M Reboussin
Dustin T Williams
Eva Lavant
Henry A Erlich
Janelle A Noble
Joan E Hilner
P2860
P304
P356
10.1177/1740774510373494
P433
P577
2010-07-01T00:00:00Z